Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients

NCT01822340 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Growth Hormone Deficiency

Interventions

DRUG: HM10560A
DRUG: Genotropin

Sponsor

Hanmi Pharmaceutical Company Limited